Sort
30,917 grants matching “tumor microenvironment”
Fibroblast Activation Protein in the Tumor Microenvironment in Lung Cancer
$352,202Ellen Pure' · Wistar Institute · R01 · FY2011 · CA
Engineering S. typhimurium for metastatic colorectal cancer
$352,142Tal Danino · Columbia Univ New York Morningside · R01 · FY2024 · EB
Disparities in Immuno-oncology Outcomes in Detroit (DIODE)
$352,141Kristen S. Purrington · Wayne State University · P20 · FY2024 · CA
Adenosine in Tumor-Host Interaction
$352,106Mikhail M Dikov · Vanderbilt University · R01 · FY2011 · CA
Project 4: Thymic and peripheral Aspects of T cell Aging and Rejuvenation
$352,087Janko Nikolich-Zugich · University Of Arizona · P01 · FY2020 · AG
Project 2: Cellular topography and function of the breast cancer tissue microenvironment
$352,077Robert Michael Angelo · Stanford University · U54 · FY2024 · CA
Evaluation of an implantable microdevice for rapid cancer drug screening directly in T cell lymphoma patients
$352,052Cecilia Larocca · Brigham And Women'S Hospital · R37 · FY2024 · CA
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors
$352,047Timothy Anthony Yap · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Dissecting the source and mechanisms of IL-17-mediated modulation of pancreatic tumorigenesis
$352,047Florencia McAllister · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
Dissecting and targeting tumor-TME crosstalk to forestall acquired KRASG12C inhibitor resistance in NSCLC.
$352,047Ferdinandos Skoulidis · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
$352,047Juan Fueyo · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
DELINEATING THE EVOLUTION AND ECOLOGY OF CHEMORESISTANCE IN BREAST CANCER WITH SINGLE CELL GENOMICS
$352,047Nicholas Navin · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$352,047Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression
$352,047Guocan Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Understanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancer
$352,047Ferdinandos Skoulidis · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Dissecting and targeting mechanisms of genomic instability-triggered immune evasion in RBM10-deficient non-small cell lung cancer
$352,047Ferdinandos Skoulidis · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Identification of USP13 as a therapeutic target for ovarian cancer
$352,044Xiongbin Lu · Indiana University Indianapolis · R01 · FY2019 · CA
Project 1: Active immunotherapy combined with checkpoint modulation for glioblastoma
$352,032Robert M Prins · University Of California Los Angeles · P50 · FY2017 · CA
Tumor cell and microenvironment changes causing antiangiogenic therapy resistance
$352,024Manish Aghi · University Of California, San Francisco · R01 · FY2021 · NS
Project 1: Mechanisms of Stiffening in Liver Cancer
$352,015Dennis E. Discher · University Of Pennsylvania · U54 · FY2016 · CA
Function of Membrane Type Matrix Metalloproteinase
$351,975Stephen Weiss · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Analyzing protein homeostasis pathways in multiple myeloma stem-like cells
$351,975Nami McCarty · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · CA
Targeted therapies in cutaneous melanoma
$351,975Andrew E Aplin · Thomas Jefferson University · R01 · FY2024 · CA
A preclinical integrated PET/EPR imaging system
$351,960Chien-Min Kao · University Of Chicago · R01 · FY2021 · EB
Polarizing Macrophages to Tumor Suppressors by Blocking Multiple CCR2 Chemokine Receptor Epitopes
$351,954Juliane Nguyen · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA